Domov › Rak glave in vratu › Tennessee › Nashville
Klinične študije za Rak glave in vratu v Nashville, TN
21 študij za Rak glave in vratu išče udeležence na lokacijah v Nashville in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.
Uradno besedilo študije (angleško)
Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Vključevanje udeležencevFaza 1/2
- Sarah Cannon Research Institute, Nashville
FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
Vključevanje udeležencevFaza 2/3
- Site#0126, Nashville
- Site #0116, Nashville
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Vključevanje udeležencevFaza 2
- SCRI Oncology Partners, Nashville
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
Vključevanje udeležencevFaza 1
- Sarah Cannon Research Institute - Pharmacy, Nashville
- SCRI Oncology Partners, Nashville
DESTINY-PANTUMOUR04
Vključevanje udeležencevOpazovalna študija
- Research Site, Nashville
A Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCC
Vključevanje udeležencevFaza 1
- Sarah Cannon and HCA Research Institute, Nashville
Self-Management for Head and Neck Lymphedema and Fibrosis [PROMISE Trial]
Vključevanje udeležencev
- Barbara Murphy, Nashville
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
Vključevanje udeležencevFaza 1/2
- Sarah Cannon Research Institute Oncology Partners (SCRI-Nashville), Nashville
Window Trial of Fluorescently Labeled Panitumumab (Panitumumab-IRDye800) in Head and Neck Cancer
Vključevanje udeležencevFaza 1
- Vanderbilt University Medical Center, Nashville
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
Vključevanje udeležencevFaza 1/2
- Sarah Cannon Research Institute, Nashville
Safety and Feasibility of Nivolumab-IRDye800CW in Patients With Head and Neck Squamous Cell Carcinoma (HNSCC)
Vključevanje udeležencevFaza 1
- Vanderbilt University Medical Center, Nashville
Photobiomodulation in Head and Neck Cancer-Related Chronic Lymphedema
Vključevanje udeležencev
- Vanderbilt University Medical Center, Nashville
A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma
Vključevanje udeležencevFaza 3
- GSK Investigational Site, Nashville
High-Resolution PET-CT Imaging for Surgical Margin Visualization
Vključevanje udeležencev
- Vanderbilt University Medical Center, Nashville
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
Vključevanje udeležencevFaza 1/2
- Sarah Cannon Research Institute, Nashville
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
- Vanderbilt-Ingram Cancer Center, Nashville
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Vključevanje udeležencevOpazovalna študija
- Massive Bio SYNERGY-AI site, Nashville
Tissue Sample Collection From Patients With Head and Neck Cancer and From Healthy Participants
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
- Vanderbilt-Ingram Cancer Center - Cool Springs, Nashville
- Vanderbilt-Ingram Cancer Center at Franklin, Nashville
- Veterans Affairs Medical Center - Nashville, Nashville
- in še 1
A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors
Vključevanje udeležencevFaza 1/2
- Tennessee Oncology, Nashville
Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
Vključevanje udeležencevFaza 1
- Vanderbilt University Medical Center, Nashville
Gabapentin & Ketamine for Prevention/Treatment of Acute/Chronic Pain in Locally Advanced Head and Neck Cancer
Vključevanje udeležencevFaza 1/2
- Vanderbilt-Ingram Cancer Center, Nashville
Študije za Rak glave in vratu v drugih mestih
- Houston, TX30 študij
- Boston, MA22 študij
- New York City, NY21 študij
- St. Louis, MO15 študij
- Dallas, TX12 študij
- Pittsburgh, PA11 študij
- Los Angeles, CA10 študij
- San Antonio, TX10 študij
- Baltimore, MD10 študij
- Washington, DC10 študij
- Durham, NC10 študij
- Chicago, IL10 študij
Druge študije v Nashville
- Nemalicelični pljučni rak97 študij
- Rak dojke81 študij
- Metastatski rak70 študij
- Kolorektalni rak69 študij
- Rak (vse vrste)65 študij
- Rak jajčnikov49 študij
- Rak prostate43 študij
- Rak pljuč40 študij
- Ploščatocelični karcinom glave in vratu39 študij
- Rak trebušne slinavke39 študij
- Rak endometrija38 študij
- Melanom33 študij
Vir: ClinicalTrials.gov, podatki pridobljeni 6. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.